Introduction
Inflammation is initiated by the infiltration of inflammatory, immune [2] [3] [4] Silicosis is an occupational lung disease resulting from the inhalation of silica dust which causes chronic inflammation and progressive pulmonary fibrosis. Inhaled silica particles are first ingested by alveolar monocytes/macrophages, which then release oxygen free radicals and lysosomal enzymes which damage lung tissue. 5 They also release pro-inflammatory cytokines which recruit more inflammatory cells to secrete these fibrogenic mediators inducing the proliferation of fibroblasts and collagen synthesis. 6 '7 Hepatic fibrosis is one of the chronic inflammatory liver diseases. It is a complex process that involves the deposition of extracellular matrix components, activation of cells capable of producing inflammatory mediators, cytokines, and tissue remodelling. Unbalanced production of pro-inflammatory cytokines and inflammatory mediators has been 9 reported in chronic liver diseases.' In cirrhotic liver, levels of IL-1, TNF, and IL-6 are increased. TGF-[3 is also involved in collagen synthesis and chronic liver diseases.
As is well known, IL-6 is a regulatory factor which participates in the growth, differentiation and activation of cells. It is produced and secreted by various organ cells, and plays an important role in defensive mechanisms of the human body. 10 IL-6, first discovered in the culture supernatants of monocytes, has been reported to induce the production of antibodies by B cells. Since the successful cloning of the cDNA of IL-6,12 has been reported to serve as a growth factor for B cell hybridoma and plasmacytoma, and as a factor participating in haematopoiesis. 4 Further, IL-6 has been reported to have the functions of stimulating the activation and growth of T cells; 15 U/ml from the extrapolation of the standard MgCl2, 5 btg/ml BSA), 1 l.tl (20 pmol) of 5'-end curve obtained using recombinant human TNF-a primer (5'-ATGAACTCCTTCTCCACAAGCGC-3'), (Genzyme). The activity of IL-6 was determined 1 !1 (20 
Results
Cytotoxicity of extracts of S. tetrandra $. Moore..
The cytotoxicity of the extracts of S. tetrandra S. Moore were determined as described Materials and Methods. Figure 1 shows were incubated with various concentrations of S. tetrandra S. Moore for h and stimulated with 100 lg/ml silica. After 48 h incubation, the culture supernatants were collected, centrifuged, dialysed, and filtered to remove the extracts. IL-6 production was bioassayed as described in Materials and Methods (control, silica only; 32 U/ml IL-6). (B) Rat alveolar macrophages (1 x 106 cells/well) were incubated with 10 Ig/ml S. tetrandra S. Moore for h, stimulated with silica, and assayed for IL-6 as described in (A) ( (Fig. 2C) . In this case, cells were treated with 10 txg/ml pokeweed mitogen (PWM) and 10 l.tg/ml extracts. Extract A and B showed dramatic inhibitory effects on IL-6 production. Next, the effects of S. tetrandra S.
Moore on IL-6 production in vivo were analysed.
In the experimental silicosis model, IL-6 activities in the serum (Fig. 2D) When IL-6-CAT construcff" was used to see the effects of Extract B on IL-6 promoter activity, the IL-6 promoter activity induced by LPS plus PMA was suppressed about 60% by 10 l.tg/ml of the Extract B. However, acanthoic acid (A), another natural product which had no effect on IL-6 production, 34 did not inhibit the IL-6 expression (Fig. 3B,C Moore.. IL-6 is known as a cytokine which causes fibrogenesis and induces collagen synthesis in rat fibroblasts. 5 Based on the observation of the inhibitory effects on the IL-6 production, their were preincubated with 10 ig/ml Extract A for h and stimulated with 100 lg/ml silica. After 48h incubation, the culture supernatants were assayed for collagen production by ELISA using anti-collagen type antibody. (B) The experimental silicosis was induced as described in Materials and Methods. Then, Extract C (40 mg/injection) was orally injected into the silicosis rat twice per week for 17 weeks. The lung tissue (0.1 g) was hydrolyzed and assayed for collagen content by measuring hydroxy proline. Data represent the percentages of control (normal lung).
inhibitory effect on the collagen synthesis in rat pulmonary fibroblasts and pulmonary tissues was determined. As a result, it was observed that the amount of synthesized collagen was significantly decreased in the culture supernatants of rat pulmonary fibroblasts which were treated with 10 g/ml of Extract A compared with the control (Fig. 4A) . Furthermore, in vivo effects of S. tetrandra S. Moore (Extract C) on the collagen synthesis in rat pulmonary tissues was tested by injecting 500 mg of silica and 40 mg of Extract C orally into the rats twice a week for 17 weeks, and then the amount of hydroxyproline was measured as described in Materials and Methods.
In Fig. 4B, (Fig. 6A) . Further, sGPT in the blood samples obtained from the rats treated with Extract B decreased more than 60% (Fig. 6B ).
In the liver of the rats administered with CC14
only (Fig. 7B) , the nodule formation of hepatic lobules with the thickened fibrous bands was remarkable compared with the normal liver (Fig.  7A ). In the liver of the rats administered with CC14 and Extract B (Fig. 7D) It reduced the collagen production, and granuloma formation and fibrosis in the lung.
Hepatocirrhosis is characterized by the fibrogenesis of the whole liver, complete disruption of liver parenchyma by the fibrous septa, and formation of regenerative nodules. It is derived mostly from a chronic hepatitis or chronic alcoholism, however, the precise causes are unknown. We previously reported that in vivo administration of IL-6 could induce the early stage of liver cirrhosis. 7 In a hepatocirrhosis patient, the amount of cytokines, e.g. IL-6 which is involved in the inflammation and fibrogenesis, is in an increased state. Based on its effects on IL-6 production, these inhibitory effects in vivo might be due to reduction of IL-6 and/or other inflammatory mediators induced by IL-6 such as reactive oxygens free radicals.
Various root extracts of S. tetrandra S. Moore which inhibit the production of interleukin-6, can be used for the preparation thereof and pharma- 
